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ABSTRACT 
Protein proteinase inhibitor constitute about 
10% of the total plasma protein in mammals. They 
have a variety of physiological functions, such as 
fibrinolysis, coagulation and inflammatory 
reactions.oC -1- proteinase inhibitor , a serine 
proteinase inhibitor or more appropriately called 
o^l-antitrypsin has been studied in much detail in 
human, goat, pig etc. In this dissertation 
isolation and characterization of oC-l-antitrypsin 
(oC i^^T) from buffa-Io plasma has been described. 
The proteinase inhibitor ( oC jAT) has been 
isolated by ammonium sulfate precipitation and 
purified by ion exchange chromatography on DEAE-
Sephacel. The inhibitor obtained is a glycoprotein. 
Sodium dodecyl sulfate polyacrylamide gel 
electrophoresis of the inhibitor gave a molecular 
weight of about 5lKd. Neutral hexose content, 
determined by the method of Dubois et al. (1956) 
was found to be 10.9%. Two residues of free 
sulphydryl groups were determined by Ellman's 
reagent. The ultraviolet absorption spectrum of 
native proteinase inhibitor (oC ^ AT) gave a peak at 
279nm which suggest that both tyrosine as well as 
tryptophan residues are present. The UV absorption 
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spectrum of urea denatured inhibitor ( ^ C^ j^ AT) 
indicates a blue shift which confirms that 
conformational changes have taken place. The change 
in conformation, supported by UV difference 
spectrum indicate that tyrosine residues in £>C ^ AT 
are of exposed nature. Fluorescence emission 
measurements suggest that the protein (inhibitor) 
is a class B' protein i.e. both tyrosine and 
tryptophan are present. 
The inhibitory activity was determined by 
using BAPNA and trypsin. The results obtained thus 
suggested that stoichiometry of trypsin binding to 
0(CAT was found to have a molar ratio of 1:1. The 
complex formation in a molar ratio of 1:1 as well 
as the kinetic parameters determined by double 
reciprocal plot (Lineweaver - Burk) suggest that 
inhibitor { oC ^ AT) isolated is a competetive 
inihibitor. 
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iNTRoduCTION 
INTRODUCTION 
The plasma proteinase inhibitors constitute 
by weight the third largest group of functional 
proteins. The other two proteins found in abundance 
in mammalian plasma are albumin and 
immunoglobulins. About 10% of the total protein in 
plasma are the proteinase inhibitors. They are 
implicated in controlling unwanted tissue turnover, 
fibrinolysis, complement activation, inflammatory 
reactions and coagulation. The activity of these 
proteases is governed mainly by a variety of 
proteins occurring in extracellular fluids and 
capable of inactivating or influencing the 
elimination of the enzymes from blood and 
extracellular fluids. Antiproteinase deficiency can 
result in excessive proteinase induced tissue 
damage (Pemberton, Miller, John and Scudamore 
1993) . 
Jacobsson (1955) localised the major trypsin 
inhibitors in the electrophoretic ^-^ zone and Bundy 
and Mehl isolated the inhibitors in 1959. Schulze 
et al. (1955) had isolated 3.5 S oc ^ -
glycoprotein without observing its capacity to link 
ferine proteases which they recognised in 1962. 
They coined the namecC^ - antitrypsim to replace 
their earlier designation of 3.5 S <^. 
glycoprotein. Genetic varinats of << ^ A^T had been 
recognized as "Prealbumin" by Fagerhol and Braend 
(1965), 
P r o t e i n a s e i n h i b i t o r s can be broadly c l a s s i f i e d as 
shown in Table I . 
Table - I 
Major Protease Inhibitors in Plasma 
S.No. Name Abbreviation MM* Mean Enzymes 
Concentration inhibited 
(gm/liter) in vivo 
l . C > C - A n t i t r y p s i n ^ AT 55 ,000 2 Se r ine 
p r o t e a s e s 
2. Antichymotrypsin Achy 69,000 0.4 Serine 
proteases 
3. Inter-<-trypsin^ I«ci 160,000 0.4 — . 
4. cC2-Macroglobin^ o^ M 725,000 2 Endopeptidases 
a. Crawford (1973), Ganrot (1972), Chan et al.(1972) . 
b. Scliulze et al. (1962). 
c. Heide et al, (1965), Heimburger et al. (1971). 
d. Jones et al. (1972), Ganrot and Scheriters (1967), Barret 
and Starkey (1973). 
* MW = Molecular weight (daltons). 
utilising acid starch gel electrophoresis and by 
Laurell and Eriksson (1963) using agarose gel 
electrophoresis and crossed Immunoelectrophoresis 
(Axelsson and Laurell, 1965). Fagerhol (1968) gave 
the basic system for classification of the genetic 
0(^ AT variants which are included under the name of 
the Pi system. P standing for protease & i for 
inhibitor. Twenty-three Pi alleles have been 
recognised (M.K. Fagerhol, personal 
communication, 1974) . The genetic variants differ 
usually in the position of the protein band pattern 
into which oC-^AT is resolved on prolonged 
electrophoresis just above their isolectric points 
as an expression of the microheterogeneity of OCiAT. 
When describing new genetic variants it is 
necessary to analyze the proteins.(a) With starch 
gel electrophoresis (pH 4.95), followed by (b) 
crossed immune- electrophiresis, (c) agarose gel 
electrophoresis (pH 8.6) (d) immunochemical 
quantitation of inhibitory activity. 
Molecular structure and chemical composition 
Physicochemical properties 
OC-^ AT is a simgle polypeptide chain which 
contains 12-14% carbohydrate and has a molecular 
weight of 49,000 to 60,000 daltons. (Crawford, 
.1.973; Chan et al., 1973; Potempa et al., 1995) as 
determined by different techniques (Table II) . 
2. Amino Acids and Carbohydrates 
Two reports on the amino acid and 
carbohydrate content ofoC^AT given in Table III. 
These show minor differences besides the variation 
in half-cystine content from one to two residues. 
This amino acid is highly sensitive to oxidative 
destruction during acid hydrolysis. 
Mechanism of action of proteinase inhibitors 
Standard Mechanism : Except for serine protinase 
inhibitors, the mechanism of action of proteinase 
inhibitors is still not well established. I have 
thus concentrated only on oC-,Pl class of inhibitors 
or to be more specific only on c^CiAT. Most 
proteinase inhibitors bind to same site on the 
enzyme as the substrate molecule thereby showing 
competitive inhibition. The inhibitors may be 
highly specific and inhibit only the target 
enzyme(s) or may show broad specificity and also' 
inhibit cognate enzymes (enzymes which recognize 
the reactive site of the inhibitor (Laskowski, 
1986)). Wilcher and Dolovan (1973) suggested that 
Table - II 
Physicochemical Chemical Properties of oC^AT 
Properties Values Reference 
Molecular weight by 
sedimentation 
equilibrium (daltons) 
Molecular weight by 
SDS-PAGE (daltons) 
49,500 Crawford (1973) 
Molecular weight by 
gel filtration (dalton) 
P (Isoelectric point) 
50,300 
54,000 
58,000 
60,000 
Partial specific volume 0.728 
4.8 
,1% A °278 (extinction coeff.) 5.3 
S2Q, W (sedimentation 
constant) 
D20/ W (cm sec"-*-) 
Helical content % 
Pleated sheet % 
3.41 
5.2 
35 
44 
Crawford (1973) 
Chan et al. 
(1973) 
Potempa et al. 
(1995) 
Potempa et al. 
(1995) 
Crawford (1973) 
Schonenberger 
(1995) 
Bundy and Mehl 
(1959) 
Bundy and Mehl 
(1959) 
Bruch et al. 
(1988) 
Bruch et al. 
(1988) 
Overall dimensions 67A°x32A°x32A° Lobermann(1984) 
TABLE - III 
Amino Acid and Carbohydrates Content of Human oC^AT 
Residues/45,OOOgm^ Residues/50,OOOgrn^ 
Aspartic Acid 
Threonine 
Serine 
Glutamic Acid 
Proline 
Glycine 
Alanine 
Valine 
Methionine 
Isoleucine 
Leucine 
Tyrosine 
Phenylalanine 
Lysine 
Histidine 
Arginine 
Half-Cystine 
Tryptophan 
Mannose 
Galactose 
Fucose 
N-Acetyglucosamine 
Sialic Acid 
38 
26 
18 
46 
15 
19 
22 
21 
07 
16 
39 
06 
23 
39 
12 
06 
02 
02 
14 
-
1 
10 
06 
44 
31 
22 
50 
16 
22 
24 
23 
08 
18 
45 
07 
29 
32 
13 
07 
01 
02 
07 
05 
10 
06 
a. Heimburger et al. (1964, 1971) 
b. Crawford et al. (1973) 
<?CiAT binding to enzyme provides a mechanism for 
destruction of these enzymes since EI complexes are 
not normally detectable in plasma. 
oC^ AT inhibits the pancreatic enzyme trypsin, 
chymotrypsin (Swick et al., 1966) and elastase 
(Kaplan, 1973), granulocytal enzymes elastase 
(Ohlsson, 1971; Janoff, 1972; Liebermann and 
Kaneshiro, 1974; Ohlsson and Olsson, 1974) and 
collagenase (Ohlsson and Olsson, 1974). The 
reaction between the enzyme and inhibitor is of 
second order, showing 1:1 stoichiometry (Bundy and 
Mehl, 1959; Imamura and Karabara, 1992). The enzyme 
inhibitor complex is stable on electrophoresis (pH 
9 to 5) and have a relative mobility intermediate 
of the components. 
A group mammalian proteolytic enzyme i.e. 
plasmim (Rimon et al., 1966; Heimburger et al., 
1969, 1972a) and spermal acrosine (Fritz et al., 
1972b) are slowly inactivated by oC-, AT in vitro. 
The enzyme inhibitor interaction can be 
expressed by the following equation (Lebowitz and 
Laskowski, 1962; Finkenstadt and Laskowski, 1965, 
1967; Ozawa and Laskowski, 1966) 
it 
^on ^on * 
E + I ^ C =^  E + I -(1) 
^off ^off 
where E is the enzyme, I and I are the virgin and 
modified form of the inhibitors, and C is the 
stable inactive enzyme inhibitor complex. Residual 
activity shown by the enzyme inhibitor complex can 
be due to -
1. Contamination of the enzyme preparation by an. 
enzyme that is not recognised by the inhibitor. 
2. Under some assay conditons some of the 
complex dissociates to liberate free enzyme which 
shows residual activity. 
The association constant, K^, for the complex 
formation is given by the equation 
^on E^J 
a^ = ~K— = -rEirir" ^^^ 
off 
For many proteinase - proteinase inhibitor pairs 
-1 O _ 1 
the values of K are very large (1.8 x lO"^ -^  M ) 
(Vincent and Lazdunski, 1972) but usually range 
between 10^ -10"'"^ . The K^ value for small synthetic 
inhibitors is usually between 10 - 10^ M"-^ . K^ ^^  
values for most inhibitors are of the order of 10 
M"-"- S~^ (Finkenstadt et al., 1975; Empie and 
Laskowski, 1982; Ardelt and Laskowski, 1985; Hiromi 
et al., 1985). 
The residues forming the reactive site 
peptide bond which is hydrolysed during complex 
10 
formation with the enzyme are named P-j^  and P^' • The 
K^g^/Kj^ value for hydrolysis is about 10^ - 10^ M~-^  
S~ (Fersht, 1985) indicating that inhibitors are 
substrates (Estell and Laskowski, 1980; Ardelt and 
Laskowski, 1983). this is also supported by X-ray 
crystallographic data of the stable E-S complex. 
Though the stable complex C can be formed by either 
I or I the rate of complex formation is greater 
with virgin inhibitor. 
This mechanism is followed by many inhibitors" 
which may differ in molecular weight, amino acid 
composition and other physiochemical properties. 
The members of oC-^AT class follow at least 
part of the standard mechanism and form equimolar 
complexes with their target enzymes via reactive 
site region however, they differ from most other 
inhibitors following this mechanism in two ways -
1. The modified inhibitor is inactive. 
2. The E-I interaction is so strong as to imply 
the formation of covalently stabilozed complex. 
Cleavage of the reactive site peptide bond of-
the members of the ^^AT class results in a 
modified protein that is no longer inhibitory. One 
of the unique properties of the members of this 
class is their ability to form complexes with their 
11 
target enzymes. This implies that covalent. 
interaction must exist between proteinase and 
inhibitor. 
Devations from standard mechanisms 
The members of ^^^AT class are all high 
molecular weight single chain glyscprotein with 
single reactive centres. Most of them follow at 
least a part of the standard mechanism forming 
equimolar complexes with their target enzymes via 
reactive-site region. Despite similarities there 
are two points of deviation of cC^AT class from 
those operating via the standard mechanism - one is 
that modified inhibitors are inactive and cannot 
recombine with a proteinase and second is that the 
strenght of the interaction is so strong as to 
imply a covalently stabilized complex, 
a. Inactive Modified Inhibitors : Cleavage of the 
reactive site peptide bond of members of the oCiPI 
class results in a modified protein that is no 
longer inhibitory, Thr rate of breakdown of 
complexes to form inactive inhibitors has also been 
determined for various oC-j^ AT complexes. Some 
examples of inactive modified inhibitors are -
Thrombin, Factor IXa and Factor Xa each produce a 
modified AT III that is unable to inhibit Thrombin; 
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Chymotrypsin and Cathepsin G produce an inactive 
form ofOC-iAchy; and trypsin causes the formation of 
a modified form of oC-^Pl-
b. Covalent Complex Formation : One of the unique 
properties of the members of cCi^^ class is there 
ability to form complexes with their target enzymes 
that resist dissociation by denaturing agents such 
as sodium dodecylsulfate or urea. This implies that 
a covalent interaction must exist between 
proteinase and inhibitor. If a bond is formed it 
must exist between the 6^ of the catalytic serine 
of the enzyme and the carbonyl carbon of the 
reactive-site bond of the inhibitor. Inhibition is 
presumed to result from the establishment of a 
stable acyl derivative. 
Biological Function 
oCiAT is synthesized by in vitro cultures of 
hepatocytes (Gitlin and Biasucci, 1969) . In some 
diseased conditions Sharp (1971) observed a large 
number of inclusion bodies in the endoplasmic 
reticulum of the hepatocytes. These globules 
reacted strongly with antibodies to^^AT. It was 
suggested that the globules consist of ^lAT 
synthesized and retained within the endoplasmic 
reticulum. The inclusion bodies were recently 
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isolated and proved to consist of aggregatedoCiAT 
(Eriksson and Larsson, 1974). The doubling of^ C^j^ AT 
level in plasma during administration of estrogens 
for therapeutic or contraceptive purposes may be 
attributed to a synthesis enhancing effect of 
estrogens (Fagerhol and Laurell, 1970). Increased 
synthesis also leads to raised plasma level of oC-j^AT 
during most inflammatory reactions. 
The normal mean plasma level is estimated to 
be 2.0-2.2 gm/liter and the range has an SD of ±0.3 
to 0.4 (Kueppers, 1967; Ganrot, 1972). Trypsin 
inhibitory capacity of 0.95 gm/litre plasma 
(Fagerhol and Laurell, 1970) (coefficient of 
variation 19%) whereo<^ AT is responsible for 90-95% 
of the inhibition when the analysis is run with 
benzoylarginine-p-nitronilide as substrate. Ranges 
reported are often wider and varying since sera of 
uneven quality have been used as primary standards. 
The intraindividual variation is less than the 
variation in population. Similar level of oCiAT is 
found in adults and in full term newborns (Laurell, 
1968) while the concentration is lower in premature 
births and often markedly lower in the respiratory 
distress syndrome (Kotas et al., 1972; Mathis et 
al., 1973). 
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In most acute inflammatory conditions caused 
by infection or necrosis the oC^ AT content increases 
like the acute phase reactants oC-j^ -glycoprotein, 
haptoglobin and fibrinogen (Laurell, 1972b). The 
diseases of connective tissue, cartilage and bone 
usually induce markedly increasedeCj^-glycoprotein 
and haptoglobin values, but in these diseases the 
oCj^AT reaction is much less marked than in most 
inflammations of septic or necrotic origin (Cleve-
and Behrend, 1966). Increased tfC^AT plasma 
concentration is a characterstic finding in acute 
hepatitis and in active liver cirrhosis which are 
not accompanied by increased synthesis of other 
acute phase reactants (Kindmark nad Laurell, 1972) . 
One of the major functions attributed to cC^AT is 
inactivation of protease released mainly 
intracellularly during the activity of 
granulocytes. It forms firm complexes with these 
enzymes. These are absorbed locally by macrophages 
or eliminated via the lymphatics c<-,AT may also, 
serve a function in the protection against 
pacreatic and bacterial enzymes. ^,AT also 
functions as an inhibitor of the acrosomal sperm 
proteinase (Schumacher, 1971; Fritz et al., 1972b). 
oQ^ AT plays a major role in inactivation of numerous 
15 
serine proteinase. One of its primary role is in 
the regulation of neutrophil elastase. In 
inhibitory deficiency states, free elastase can 
cause the abnormal degradation of connective 
tissue, ultimately resulting in various diseasesed 
states, especially emphysema (Perlmutter and 
Pierce, 1989). Proteolytic inactivation of the 
inhibitor leads to connective tissue diseases in 
individuals with normal inhibitor levels 
(Desrochers et al., 1991, 1992). Carell and Travis, 
(1985) Carell and Owen, (1985) believed that, 
oxidation and proteolytic mechanism for 
inactivation of inhibitors are utilized in normal 
tissue modelling. 
Proteolysis is one of the most important 
biological functions (Neurath, 1984). It is always 
involved in biological protein synthesis, in 
control of protein destination (signal activation), 
in control of protein death (protein turnover) . It 
is also involved with facilitating the transport of 
large systems or of an entire organism. Proteolysis 
is also essential for ingestion of foreign food 
stuffs. Since proteolysis is of great importance it 
must be controlled and one of the steps in the 
control of proteolysis is the existence of 
16 
proteinase inhibitors. When serum levels of -^ AT 
are below 35% of the normal, the inhibitor 
concentration becomes insufficient to protect the 
lower respiratory track from its burden of 
neutrophil elastase placing such individuals at a 
high risk for development of pulmonary emphysema. 
ExpERIMENJAl 
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MATERIALS AND METHODS 
A. MATERIALS 
(i) Proteins and Enzymes 
Bovine serum albumin fraction V (Batch No. T-
818090) was purchased from Sisco Research 
Laboratories, India. Ovalbumin (Lot No. 23F-8175) 
«4chymotrypsinogen A (Lot No. lllF-8055) trypsin' 
(Batch No. T-8253, Lot No. 118C-8050) and 
cytochrome C (lot no. 63f7299) were the products of 
Sigma Chemical Company U.S.A. 
(ii) Media for ion exchange chromatography 
DEAE-Sephacel (Lot No. 55F-0367) was 
purchased from Sigma Chemical Company U.S.A. Wet 
Bead size of 40-160 microns having a, capacity of 
100-140 eqv. per ml of gel volume. Average 
molecular weight IxlO . 
(iii) Reagents for electophoresis 
Dimethyldichlorosilane and coomasie-
bria]liant blue G-250 were purchased from Sigma 
Chemical Company U.S.A. Bromophenol blue and N, N, 
N', N' Tetramethylethylenediamine were obtained 
from P.P.H. Poland and BDH England respectively. 
Acrylamide, N, N' - methylenebisacrylamide, 
ammonium persulphate, Tris, glycerol, sucrose, 
glycine, acetic acid, chloroform and methanol were 
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the products of Qualigens Fine Chemical India. 
(iv) Other reagents 
oC-Benzoyl-Arginine,p-Nitroanilide Hydrochlor-
ide (BAPNA) (Lot No. - 122 H0071) was a product of 
Sigma Chemical Company U.S.A. Sodium acetate was 
obtained from B.D.H. India. Sodium azide was 
purchased from Loba Chemie, India. Sodium chloride, 
sodium hydroxide and sodium potassium tartarate 
were obtained from Qualigens Fine Chemicals India. 
Analytical grade samples of glacial acetic acid, 
sulphuric acid, hydrochloric acid, orthophosphoric. 
acid, sodium phosphate monobasic and dibasic, 
copper sulphate, potassium permanganate, methanol, 
liquid bromine were used. 
(V) Miscellaneous 
Dialysis sacs of different flat widths i.e. 
25 mm (Lot No. 82H-0050) and 43 mm (Lot No.-
92H0291) were purchased from Sigma Chemical Company 
U.S.A. Millipore filters of pore 0.45JU and 13 mm 
diameter were the products of Millipore Product 
Division, Bedford U.S.A. Solid glass beads were 
obtained from Kimble Resistant Glass (U.S.A.). 
Standard buffer tablets of pH 4.0, 7.0 and 9.2 were 
purchased from Glaxo (India). 
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Glass distilled water was used throughout 
this study. 
Serum was extracted from fresh buffalo blood 
obtained from slaughter house. 
B. METHODS 
(i) pH - measurements 
Measurements of pH were carried out on Elico 
pH meter, model LI-IOT, using ppc Elico combined 
glass electrode type CL-51. Before pH measurements 
the pH meter was routinely calibrated by standard 
buffer of pH 4.0, pH 7.0 and pH 9.2 for measuring 
the pH value in acidic, neutral and alkaline pH 
range respectively. 
(ii) Optical measurements 
A Shimadzu double beam spectrophotometer 
model UV-150-02 was used for light absorption 
measurements in the ultraviolet as well as in the 
visible region. Silica cells of 1 cm path length 
were used for measurements in the ultraviolet and 
visible region respectively. Fluorescence 
measurements were performed on a Shimadzu 
Spectrofluorophotometer, model RF-540 equipped with 
a data recorder model DR-3. 
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(iii) Determination of protein concentration 
Protein concentration was determined by the 
following methods. 
(a) Method of Lowry et al., (1951) : 
In this method of protein estimation two 
reagents were used namely, Folin phenol and copper 
sulphate which were prepared as follows. 
Preparation of Folin Phenol : This reagent was 
prepared, according to the method recommended by 
Folin and Cicalteau (1927) . To a two litre round 
bottomed flask, wrapped with a black paper were 
added 200g of sodium tungstate, 50g of sodium" 
molybdate, 44 ml of orthophosphoric acid (90.5%), 
200 ml of 11.4N HCl and 1400 ml of water. The 
mixture was refluxed for about 10 hours. This was 
followed by addition of 300g of lithium sulphate, 
100 ml of water and few drops of liquid bromine. 
The mixture was heated without condenser for 3 0 
minutes to remove excess bromine. After cooling 
total volume was made upto 2 litre with water. This 
stock solution was filtered and stored in an amber 
coloured bottle. The reagent was diluted 4 times 
with water before use. 
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Preparation of Copper Reagent : The stock solutions 
of 4% (w/v) sodium carbonate, 4% (w/v) sodium 
potassium tartarate and 2% (w/v) copper sulphate 
were prepared. These solutions were mixed in the 
ratio of 100:1:1 respectively. The reagent was 
prepared fresh and filtered before use. 
Procedure : An appropriate volume of protein 
solution in the range of 0.1 - 1.0ml was taken in a 
test tube and the total volume was made 1 ml by 
adding water or an appropriate buffer. Then 5 ml of 
freshly prepared copper reagent was added and mixed 
well. After 10 minutes, 1 ml of Folin-phenol 
reagent was added and the contents were mixed 
thoroughly. Colour intensity was recorded after 30 
minutes at 700 nm against a blank prepared in the 
same way except that the protein was replaced by 
water or buffer. 
(b) Spectrophotometric method : 
The absorbance of protein solution at 2 79 nm 
was recorded against a suitable blank. The protein 
concentration was calculated from the absorbance 
value at 279 nm using their specific extinction 
1 5-
coefficient (E icm^  ^^ that wavelength. 
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(IV) Ion exchange chromatography 
DEAE-Sephacel obtained from Sigma Chemical 
Company was used as a media for ion exchange 
chromatography. DEAE-Sephacel in preswollen form, 
suspension in 20% ethanol was resuspended in water 
and fine particles were removed by repeated 
decantation. Before packing a short and broad glass 
column was throughly washed with detergent, chromic. 
acid and finally with distilled water. The column 
was then mounted in a vertical and vibration free 
manner. The narrow bore outlet of the column was 
connected to a small latex tubing attached with a 
screw stop-cock for regulation of flow rate. A 
small amount of glass wool previously boiled in 
water was placed at the bottom of the column and 
its surface covered with glass beads. The gel 
slurry was poured into the column with the help of 
a glass rod to avoid bubble formation. The gel was 
left to settle under gravity overnight at room 
temprature. The gel bed was stabilized by passing 
several bed volumes of 0.03M sodium phosphate 
buffer having the same pH and ionic strength as 
that of the sample. Before the sample application 
the column has to be regenerated. The column was 
first equilibrated with IM, pH 3.0 sodium acetate 
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till the pH of the column matches that of sodium 
acetate. Then the column was equilibrated with 
0.5M, sodium hydroxide in the same manner. The 
column was then closed and left overnight. Then 
again it was equilibrated with IM, sodium acetate. 
Finally the column was equilibrated with phosphate 
buffer till the pH of the column matched that of 
the sample to be applied. During sample 
application the column bed was drained of the 
buffer and the sample was then applied. The sample 
was first eluted with phosphate buffer and then' 
buffer of different ionic strengths. Fraction of 
2-3 ml were collected and monitered by the method 
of Lowry et.al. (1951). 
(V) Sodium dodecyl polycrylamide gel 
electrophoresis (SDS-PAGE) 
Sodium dodecyl polyacrylamide gel 
electrophoresis (SDS-PAGE) was carried out in Tris 
glycine buffer pH 8.3 according to the method of 
Laemillie (1970). 
The gel plates were washed with detergent, 
chromic acid and finally with water. The plates 
were dried, siliconised and any sticky material was 
removed by cotton. Three plastic spacers were 
placed along the sides and bottom of the plates. 
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The plates were mounted in a vertical fashion. The 
sides of the plates were sealed with 1% agarose 
solution. Three fourth of the space between the 
plates was filled with resolving gel solution 
containing 30% (w/v) acrylamide, 0.8% (w/v) N, 
N'methylenebisacrylamite,1.5% (w/v) ammonium 
persulphate and 0.025% (v/v) N, N, N', N' -
tetramethylethylenediamine (TEMED). The solution 
was allowed to polymerize for 30 minutes at room 
temperature. Then the remaining space between the 
glass plates above the resolving gel was filled 
with stacking gel solution containing appropriate 
amount of 10% SDS. A comb was placed after pouring 
the stacking gel solution between the plates. 
Again it was left for polymerization at room 
temperature for 30 minutes. The bottom bracket, 
the side clamps and the plastic spacer at the 
bottom were removed. The lower trank of the mini 
slab gel electrophoresis apparatus was filled with 
buffer. Care was taken to avoid formation of 
bubbles at the bottom. Samples were applied in 
different wells containing 6microgram-25microgram 
of protien. Electrophoresis was carried out till 
the bromophenol blue front migrated to nearly 3/4 
of the total length of the gel. The gel was taken 
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out from between the plates. The gel was stained 
with coomasie brilliant blue containing (0.1% w/v) 
coomassie brilliant blue G-250 solution prepared in 
methanol and acetic acid. Destaining was performed 
firstly with 30% (v/v) methanol and 10% (v/v) • 
glacial acetic acid and subsequent washes were 
given with 7% (v/v) glacial acetic acid. 
Detez-mination of molecular weight of protein by 
SDS-PAGE 
Molecular weight of protien was determined by 
calculating the relative mobilities of the marker 
proteins. The relative mobility was calculated by 
dividing the distance travelled by the protein 
bands of different markers protiens with that of 
the distance travelled by the dye. 
Distance travelled by the protein band 
Distance travelled by the dye 
A straight line was drawn according to the 
method of least squares. The molecular weight of 
the protein was calculated from the following 
equation : 
Log M = -1.172 Rjj, + 5.283 (1) 
(VI) Ammonium sulphate fractionation 
Fresh blood obtained from the slaughter house 
27 
was centrifuged at 10,000 rpm for 30 minutes to 
extract serum. Serum thus obtained was further 
saturated with varying amounts of ammonium 
sulphate. 
Procedure : To 300 ml of serum obtained after 
centrifugation was added 52.8g of solid ammonium 
sulphate with gentle stirring to give 30% 
saturation. Solution was allowed to stand overnight 
at 4*"'c. Then it was centrifuged at SOOOrpm for 15 
minutes. The supernatant and precipitate were 
tested for their inhibitory activity. Precipitate 
having negligible inhibitory activity was 
discarded. 
To the remaining supernatant (210 ml) was 
added 44.94g of solid ammonium sulphate to give 80% 
saturation. The solution was again left overnight 
at 4 C and centrifuged at 5000rpm for 15 minutes. 
Supernatant and precipitate were again tested for 
their inhibitory activity. Precipitate was 
collected and dissolved in minimum amount of 0.2M 
Tris HCl buffer, pH 8.2 and extensively dialysed to 
remove ammonium sulphate. 
(VII) Measurement of trypsin inhibitory activity 
Trypsin was allowed to react with BAPNA 
resulting in the formation of p-nitroanilide which 
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has intense yellow colour at 410nin. The intensity 
of colour was used for checking the activity of 
trypsin in the presence and absence of serum. 
Procedure : Trypsin was prepared O.OOIN HCl. The 
concentration of trypsin was determined 
spectrophotometrically using an extinction 
coefficient i^'^^^j^^^) of 15.4 at 279nm. 43.5mg of 
BAPNA were dissolved in 1ml of DMSO. The final 
volume was made upto 100ml with 0.2M Tris HCl 
buffer pH 8.2. 0.1ml of trypsin was taken in three 
tubes marked as C for control, S for standard and T 
for test respectively. In tube C the enzyme was 
inactivated by adding 1ml of 30% acetic acid where 
as in tube T the enzyme was incubated with serum 
for half an hour at room temperature. The volume of 
S and T tubes was made upto 2.5ml whereas the 
volume of C was made upto 3.5ml with 0.2M Tris HCL 
buffer pH 8.2. A constant volume of BAPNA (0.5ml) 
was added in all the tubes and were incubated for 
45 minutes at 37°C. The reaction was stopped in S 
and T tubes by adding 1ml of 30% acetic acid. 
Calculations : The trypsin inhibitory activity of 
the £;erum was calculated as follows. Suppose the 
reading of the three tubes taken are 
29 
Control - C 
Standard - S 
Test - T 
Then, actual absorbance of standard 
= (Reading of standard - Reading of control) 
= S - C 
actual absorbance of test 
= (Reading of test - Reading of control) 
= T - C 
Actual absorbance 
Specific Activity = 
Enzyme Concentration 
S - C 
•Hence, units of specific activity is 
Amount of Enzyme 
100% activity of trypsin on substrate. 
Percentage inhibition of trypsin is 
Specific activity of the test 
100 - 100 X 
Specific activity of the standard 
T - C 
= 100 - 100 X % 
S - C 
S - T 
= 100 X % 
S - C 
S - T 
Finally, 100 x %inhibitor present in x ml of 
S - C 
approximate diluted serum. 
(VIII) Determination of free sulphydryl groups 
The number of free sulphydryl groups in 
trypsin inhibitors was determined by the method of 
Ellman (1964) using Ellman's Reagent [ 5 - 5 * 
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dithiobis - 2 (nitrobenzoic acid)] DTNB. 
Samples containing DTNB concentration varying 
from 0.01 mg/ml to 0.17 mg/ml were prepared. The 
inhibitor concentration was kept constant at 0.75' 
mg/ml in all the samples. Incubated at room 
temperature for 10 minutes. The intensity of yellow 
colour was read at 412nm. Optical density obtained 
was plotted against increasing molar ratio of DTNB 
to inhibitor. 
(IX) Deternination of neutral hexoses 
Neutral herxose were determined according to 
the method of Dubois (1956) To 1.0ml inhibitor 
solution was added 1.0 ml of 5% redistilled phenol 
solution and mixed throughly. 5.0 ml of 
concentrated sulphuric acid (96%) was added-
directly to the tubes, the tubes were then cooled. 
The red orange colour obtained was read at 490nm 
against an appropriate blank. Hexose content was 
determined by least squares analysis using the 
standard curve of glucose. 
(X) Stoichiometry 
Samples containing inhibitors concentration 
vrying from 0.16microM to 1.44microM were 
prepared. Enzyme concentration was kept constant at 
0.433microM. Substrate concentration was also kept 
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constant. The samples were read at 410nm against an 
appropriate blank. Inhibition was determined 
against a standard which contained enzyme and 
substrate but no inhibitor. The samples were 
incubated at 37 C for 45 minutes. Inhibition thus 
calculated was plotted against microM of. 
inhibitors. 
(XI) Ultraviolet spectral measurements 
The ultravoilet absorption spectra of 
purified inhibitors was recorded in sodium 
phosphate buffer, pH 7.0, I = 0.15 at room 
temperature in the wavelength range from 24 0 nm 3 60 
nm. The scattering corrections were made by 
extrapolation of absorbance values in the 
wavelength range 350-330 nm to the absorbing 
region. The inhibitors concentration was 1.7 mg/ml. 
(XII) Fluorescence measurements 
The fluorescence excitation and emission 
spectra of pure inhibitors were obtained in sodium 
phosphate buffer, pH 7.0, I = 0.15 at room 
temperature. Generally low protein concentration 
were used to minimize inner filters effects. 
RESUITS Ai\d DISCUSSION 
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RESULTS AND DISCUSSION 
Isolation and purification of proteinase inhibitor 
About SOOml of crude extract (serum) 
containing 25,200mg of protein, was subjected to 
30% ammonium sulfate fractionation. The supernatant 
containing significant antitrypsin activity was 
made 50% with respect to ammonium, sulfate. Both 
supernatant and precipitate were tested for 
antitryptic activity. The supernatant with higher 
antitryptic activity was further precipitated with 
80% ammonium sulfate. This fraction showed maximum 
antitryptic activity, (Table-IV). It was further 
purified on DEAE-Sephacel column equilibirated with 
0.03M sodium phosphate buffer pH 6.2, Is=0.042. The 
elution profile is shown in (Fig-2). The unbound 
protein was eluted with 0.03M sodium phosphate pH 
6.2,, Is=0.042. The protein bound to the column was 
eluted with increased ionic strength. As shown in 
two peaks were obtained. Peak I was eluted with 
buffer of Is=0.1. The protein fraction under peak 
II was strongly bound as compared to peak I and was 
therefore eluted with buffer of still higher ionic 
strength (Is=0.2). The peak I and peak II were 
checked for antitryptic activity. Peak I showed 
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TABLE-IV 
Isolation and purification of proteinase inhibitor 
from buffalo serum 
Purification Vol. 
steps (fnl) 
Total Inhibition/mg % Protein 
protein (mg) yield 
Fold 
purification 
Crude extract 300 
80% ammonium 150 
sulfate fraction 
25,200 
5,760 
0.59 
1.22 
100 
22.9 
1 
2 . 0 7 
Ion-exchange 
chromatography 
(DEAE-sephacel) 
peak II 200 340 23.23 1.35 39.38 
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Fig-l Calibration cunc for the cstiinaiion of protein b> Lour\ et al (1951) using BSA as 
standard Straight line was drawn b\ Jeas! squares anaijsjs using the equation 
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inhibition per milligram of protein to be 0.82 
whereas peak II showed inhibition per milligram to 
be 23.23 which showed nearly 40-fold increase in 
inhibition activity. Final protein yeild after ion 
exchange chromatography was 1.35% from the total 
serum protein 25,200mg. For measuring antitryptic 
activity at every step of purification BAPNA was 
used as a substrate (Erlanger, 1961 and Waheed and 
Salahuddin, 1975). 
TheO^-1-antitrypsin or the proteinase inhibitor 
obtained from buffalo serum was not found to be 
homogenonous with respect to charge during the initial 
steps of isolation as can be seen in the 
electrophoretograra, (Fig-3), shows the 
polyacrylamide gel electrophoretic pattern of 80% 
ammonium sulfate fraction (lanes A & A'). Peak I is 
shown in (lanes B & B'). Lanes (C & C ) depict the 
poly acrylamide gel electrophoretic pattern of peak 
II obtained after ion exchange. Protein band of 
peak II showed some microheterogeneity which was 
further purified by rechromatography on DEAE-
Sephacel using the same buffer systems as earlier 
(Fig-4). 
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A' B B' C^  n 
Fig-3 Pol\acr> lamidc gel eleclrophorelic pattern of 80% ammonium sulphate fraction (A & A') 
compared with peak I (B & B') and peak II (C & C) (obtained after ion exchange] on 10% 
gel Current applied was 3MA per well Samples were applied in duplicates concentra-
tion of which were H^g. 6^g and 14fxg respectively 
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Fig-4 Rechromatographic elution profile of peak II on ion exchange column using DEAE-
Sephacel Conditions were the same as that described in iig-1 
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PAGE (Fig-5) and SDS-PAGE (Fig-6) of the 
rechromatography protein fraction showed single protein 
band suggesting that the proteinase inhibitor thus 
obtained was homogenous with respect to charge and size. 
Molecular weight determination by SDS polyacrylamide gel 
electrophoresis 
The molecular weight of purified proteinase 
inhibitor was determined by SDS polyacrylamide gel 
electrophoresis in Tris glycine buffer pH 8.3 using 10% 
polyacralmide gel. The marker proteins that were used 
are listed in Table - V along with their molecular 
weights and relative mobilities. Relative mobility 
refers to the ratio of the distance travelled by a 
particular protein band to that of the marker dye. A 
straight line was drawn between log M and relative 
mobility values according to the method of least sguares 
analysis which fits the equation 
log M - -1.172 R^ + 5.283 
where M is the molecular weight of the protein whose 
relative mobility is R^. The relative mobility of the 
proteinase inhibitor was measured to be 0.49 
corresponding to the molecular weight of 51.135 
according to the calibration curve shown in (Fig-7). The 
molecular weight obtained by SDS polyacrylamide gel 
electrophoresis is in close agreement with the other 
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A A B B' 
iltei nib . 
4 
Fig-5 Polyacrylamide gel electrophoretic pattern of rechroniatographed peak II. 14^g (A & A') 
and 9fig (B & B') of inhibitors were applied on 10% polyacrylamide gels. 
In lanes (A & A') U^ig of inhibitors were applied. 
In lanes (B & B') 9^g of inhibitors were applied. 
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Fig-6 Sodium dodecyl pol>crylaniide gel elcctrophorelic pauern of prolciii inhibitor (a,AT) 
Electrophoresis was performed using Tris-gl>cine buffer pH 8 2 containing 0.1% SDS 
on 10% polyacrylamide gel About microgram of protein \\as applied The gel-s 
werestained with coomasie bnalliant blue G-250 and destained with 3U% (v/v) methanol 
and 10% (v/v) acetic acid and finally with 10% acetic acid 
In lane (A) Sjtg and lane (A') lO i^g of inhibitors were applied 
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TABLE - V 
Molecular weight and relative mobility of marker 
proteins and inhibitor used in SDS-PAGE 
Proteins Molecular 
weight (Mj 
log M Relative 
mobility (R ] 
BSA (Dimer) 132,000' 
BSA (Monomer) 68,000' 
Ovalbumin 45,000^ 
^-chymotrypsmogen 25,000 
Cytochrome C 12,000^^ 
Inhibitor 
5.12 
4.84 
4.65 
4.40 
4.093 
0.28 
0.43 
0.57 
0.75 
0.92 
0.49 
a and a' 
b 
c 
d 
Tanford (1968) 
Castello and Barker (1968) 
Weber and Osborn (1969) 
Andrews (1970) 
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O 
Relative mobility (Rm) 
Fig-7 Plot of Log M versus relatne mobility (Rm) of marker proteins and proteinase inhibitor 
(a,AT) obtained after SDS-PAGE 
The marker proteins are denoted b\ (•) The (o) denoted proteinase inhibitor 
(1) BSA (Dimer), (2) BSA (Monomer), (3) Ovalbumin, (4) a-Chymotr\psinogen, 
(5) Cvtochrome C 
molecular weight ofo^^AT reported by Crawford (1972); 
Ganrot (1973); and Potempa et al. (1995). 
Determination of free sulphydryl group 
The number of sulphydryl groups in proteinase 
inhibitor (oC,AT) were determined by Ellman's method 
(195)9) in O.IM sodium phosphate buffer ph 8.0. The 
absorbance at 412nm was plotted against increasing molar 
ratio of DTNB to inhibitor (oC^AT) ; the inflexion point 
in the curve (Fig-8) occurring at 1.9 molar ratio 
suggested the presence of 2 free sulphydryl groups in 
the inhibitor (oC^ A^T) . The values obtained were in close 
agreement with the earlier reported values in humanoC-j^ AT 
by Heimburger et al., (1971) and Crawford (1973). 
Determination of neutral hexose 
Neutral hexose content of the inhibitor (PC-J^ AT) was 
determined by the method of Dubois et al. (1956). Hexose 
content was determined by computing the values of 
inhibitor with standard curve of glucose. Standard curve 
(Fig-9) of glucose was plotted by the method of least 
square's analysis which fits the equation 
(Absorbance)^ gQj^ jjj =4.66 (amount of inhibitor) 
+ 0.032219 
hexose content from the above equation was found to be 
10.9% which is in close aggrement with the total 
carbohydrate content of 12-14% reported earlier. 
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Fig-8 Plot of DTNB titration for determing the number of free sulphvdrvl groups 
Amount of inhibitor in each tube 0 0043mM 
Absorbance at 412nm is plotted against molar ratio of DTNB to inhibitor (protein). 
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Fig-9 Standard plot of glucose for determination of neutral hexose content by the method of 
Dubois et al. Absorbance is plotted against amount of glucose added at 490nm, 
Neutral hexose content in inhibitor was determined by the least squares analysis using 
equation 
(Absorbance)^,g„^ = 4.66 (mg of hexose) + 0.0322 
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Stoichiometry of enzyme (trypsin) binding to proteinase 
inhibitor K^ A^T) 
This experment was performed to determine the 
number of moles of trypsin bound per mole of inhibitor 
(oCjiAT) , when the inhibitor is presentin excess. For this 
a number of samples were prepared with increasing molar 
ratio of inhibitor to trypsin. The samples were then 
incubated at 37*^ 0 for 45 minutes. Absorbance was 
measured at 410nm. Percent inhibition in each sample was 
calculated by comparing with a standard that contained 
trypsin but no inhibitor. Percent inhibition thus 
calculated was plotted against increasing inhibitor 
concentration (Fig-10). Rectangular hyperbolic curve was 
obtained. The number of binding sites for trypsin on 
inhibitor (oC-,AT) may vary with time and experimental 
conditions. The curve shows that inflection point is at 
a molar concentration of 0,543 M of inhibitor (oC-,AT) . 
Trypsin concentration waas kept constant at 0.433 M. The 
data obtained gave a stoichiometry one mole of inhibitor 
binding to 0.801 moles of trypsin which is closer to 1:1 
molar ratio reported forcsCj^ AT by Bundy and Mehl (1959) . 
Ultraviolet spectral results 
The ultraviolet absorption spectra of native and 
denatured proteinase inhibitor (oC^ A^T) preprations 
recorded at pH 7.0 are shown in (Fig-11). The native 
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Fig-lO Plot showing Stoichiometric binding of enzyme trypsin to inhibitor (a AT), 
Percent inhibition is plotted against amount of inhibitor. 
Inhibitor concentration was varried from 0.08(.iM to 1.44(iM, 
Amount of trypsin and substrate was kept constant. 
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Fig-111 Ultraviolet absorption spectrum of native inhibitor ^*-*) and urea denatured inhibitor 
^—•) in sodium phosphate buffer pH7 0. 1=0 15 
Inset Shows the ultraviolet difference spectrum 
ttL 
spejctrum was characterized by a peak at 279nm and a 
trough at close to 265nm. In 9M urea denatured 
proteinase inhibitor a detectable blue shift can be 
seen. The denatured proteinase inhibitor was 
characterized by possessing a peak at 276nm. The blue 
shift in denatured sample can be most likely due to 
conformational changes and exposure of chromophores, 
(Yanari and Bovery, (1960). 
The difference absorption spectra obtained by 
subtracting the absorbance spectrum of native proteinase 
inhibitor from that of denatured proteinase inhibitor is 
shown in the inset of (Fig-11) . The difference 
absorption spectra are characterized by the presence of 
a trough at 280nm and 286nm. Thus clearly spectral 
perturbation involve exposure of tyrosine residues. 
Fluorescence measurements 
The excitation and emission spectrum obtained in 
wavelength range 220-300nm and 300-400nm respectively 
are shown in (Fig-12 A & B) . The excitation wavelength 
for emission spectra, used was 276nm. The presence of 
emission maxima at about 340nm was mainly due to 
prescence of tryptophan residues. 
Kinetic parameters 
Kinetic parameters, K^^ and V^ ^^ ^^  were determined 
for (^C ^ AT from buffalo serum using synthetic substrate 
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Fig-12 (A) Fluorescence excitation spectrum of proteinase inhibitor (a^AT). 
(B) Fluorescence emission spaectrum of proteinase inhibitor (a AT). 
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BAPNA. The activity due to oC TAT was determined using 
different substrate concentration (2 x 10~ M to 4 x 
— T . — 
10 M) With constant enzyme concentration (8.75 x 10 
M][. Enzyme used was trypsin. A plot between absorbance 
at 410nm versus different substrate concentrations was 
constructed (Fig-13) which gave a value of 0.116 
absorbance units for V__,^  and K_ value was calculated to 
lUciX ill 
be 1.10 X 10 ~M. The velocity (V) values were calculated 
using the Michaelis Menten equation 
V = 
m max 
The data obtained were treated according to the 
Lineweaver and Burk (1934) plot. A plot (Fig-14) of 
1/[S] versus 1/V yielded a straight line which was drawn 
according to the method of least square's analysis and 
the value slope and intercept were found to be 4.208 and 
8.50 respectively for free trypsin. Since proteinase 
inhibitor orc^ -j^ AT is competitive in nature (Fig-14,2) 
the value of Kjj^  for trypsin inhibited by oC -j^AT is 
observed to be close to 2.0 x 10~ M which is in good 
agreement with the earlier reported values and lies well 
within the range 1.7-5.1 x 10"-^ M. (Bechet et al., (1966) 
and Inagami, (1964). 
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Fig-13 Substrate saturation curve of BAPNA hydrolysis by free trypsin. 
Amount of trypsin was i<ept constant at 0.21nig/nil. 
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Fig-14 Double reciprocal plol (Line\Nea\cr - Burk) of BAPNA h>drohs;s b} 
1 Free tr\psin 
2 Inhibited tripsin 
amount of Irjpsin was kept constant at 0 21nig/ni] 
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